Brown Advisory’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-3,278
Closed -$581K 1004
2020
Q1
$581K Sell
3,278
-11
-0.3% -$2.07K ﹤0.01% 660
2019
Q4
$629K Sell
3,289
-41
-1% -$7.4K ﹤0.01% 721
2019
Q3
$560K Buy
3,330
+1,456
+78% +$237K ﹤0.01% 724
2019
Q2
$314K Sell
1,874
-17,346
-90% -$2.4M ﹤0.01% 858
2019
Q1
$2.81M Sell
19,220
-378
-2% -$54.8K 0.01% 561
2018
Q4
$2.62M Sell
19,598
-947
-5% -$155K 0.01% 533
2018
Q3
$3.91M Sell
20,545
-304
-1% -$55.8K 0.01% 496
2018
Q2
$3.48M Buy
20,849
+11,926
+134% +$1.91M 0.01% 518
2018
Q1
$1.5M Sell
8,923
-4,522
-34% -$758K ﹤0.01% 566
2017
Q4
$2.2M Sell
13,445
-13,359
-50% -$2.4M 0.01% 514
2017
Q3
$5.49M Buy
26,804
+3,077
+13% +$716K 0.02% 382
2017
Q2
$5.77M Sell
23,727
-316
-1% -$74.3K 0.02% 391
2017
Q1
$5.74M Buy
24,043
+4,459
+23% +$1.04M 0.02% 354
2016
Q4
$4.11M Sell
19,584
-1,785
-8% -$370K 0.01% 408
2016
Q3
$4.92M Sell
21,369
-4,856
-19% -$1.19M 0.02% 373
2016
Q2
$6.06M Buy
26,225
+4,264
+19% +$983K 0.02% 335
2016
Q1
$5.89M Buy
21,961
+895
+4% +$256K 0.02% 339
2015
Q4
$6.58M Buy
21,066
+3,590
+21% +$1.07M 0.02% 331
2015
Q3
$4.75M Buy
17,476
+1,864
+12% +$573K 0.02% 362
2015
Q2
$4.74M Sell
15,612
-2,816
-15% -$840K 0.02% 356
2015
Q1
$5.49M Buy
18,428
+5,489
+42% +$1.56M 0.02% 334
2014
Q4
$3.33M Buy
12,939
+335
+3% +$83.7K 0.01% 401
2014
Q3
$3.04M Buy
12,604
+8,368
+198% +$1.87M 0.01% 399
2014
Q2
$945K Buy
4,236
+8
+0.2% +$1.66K ﹤0.01% 564
2014
Q1
$870K Buy
4,228
+78
+2% +$15.4K ﹤0.01% 557
2013
Q4
$697K Buy
+4,150
New +$649K ﹤0.01% 578
2013
Q3
Sell
-3,863
Closed -$487K 920
2013
Q2
$487K Buy
+3,863
New +$437K ﹤0.01% 593

Other funds holding AGN

Brown Advisory's AGN Position: Q2 2020 in Review

Brown Advisory sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 3,278 shares — an estimated $581K sold.

Brown Advisory first reported a position in AGN in Q2 2013 and held it in 27 quarters. The position peaked at $6.58M in Q4 2015. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Brown Advisory reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Brown Advisory sold 3,278 Allergan plc shares in Q2 2020, an estimated $581K.
  • Brown Advisory first reported a position in Allergan plc in Q2 2013 and held it in 27 quarters.
  • Brown Advisory's Allergan plc position peaked at $6.58M in Q4 2015.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Brown Advisory's 13F filing for Q2 2020, filed 14 Aug 2020.